Table 1.

Test characteristics for strategies to screen tumors of DLBCL morphology for FISH testing

HGBL-DH/TH with BCL2 rearrangementHGBL-DH with BCL6 rearrangementTotal HGBL-DH/TH
CharacteristicFrequency, n (%)SensPPVSpecNPVSensPPVSpecNPVSensPPVSpecNPV
COO: Lymph2Cx              
 GCB 549 (50) 0.99 0.12 0.53 1.00 0.43 0.01 0.50 0.99 0.88 0.13 0.53 0.98 
 GCB and UNC 683 (62) 1.00 0.10 0.40 1.00 0.50 0.01 0.38 0.98 0.92 0.11 0.40 0.98 
COO: Hans GCB 612 (52) 0.99 0.13 0.52 1.00 0.57 0.01 0.49 0.99 0.92 0.14 0.52 0.99 
DPE 380 (34) 0.75 0.14 0.69 0.98 0.53 0.02 0.66 0.99 0.70 0.16 0.69 0.96 
DPE/Lymph2Cx GCB 128 (11) 0.71 0.37 0.92 0.98 0.27 0.03 0.89 0.99 0.62 0.40 0.93 0.97 
DPE/Lymph2Cx GCB and UNC 163 (14) 0.73 0.30 0.89 0.98 0.33 0.03 0.86 0.99 0.65 0.33 0.89 0.97 
DPE/Hans GCB 150 (13) 0.73 0.35 0.91 0.98 0.29 0.03 0.87 0.99 0.65 0.38 0.91 0.97 
HGBL-DH/TH with BCL2 rearrangementHGBL-DH with BCL6 rearrangementTotal HGBL-DH/TH
CharacteristicFrequency, n (%)SensPPVSpecNPVSensPPVSpecNPVSensPPVSpecNPV
COO: Lymph2Cx              
 GCB 549 (50) 0.99 0.12 0.53 1.00 0.43 0.01 0.50 0.99 0.88 0.13 0.53 0.98 
 GCB and UNC 683 (62) 1.00 0.10 0.40 1.00 0.50 0.01 0.38 0.98 0.92 0.11 0.40 0.98 
COO: Hans GCB 612 (52) 0.99 0.13 0.52 1.00 0.57 0.01 0.49 0.99 0.92 0.14 0.52 0.99 
DPE 380 (34) 0.75 0.14 0.69 0.98 0.53 0.02 0.66 0.99 0.70 0.16 0.69 0.96 
DPE/Lymph2Cx GCB 128 (11) 0.71 0.37 0.92 0.98 0.27 0.03 0.89 0.99 0.62 0.40 0.93 0.97 
DPE/Lymph2Cx GCB and UNC 163 (14) 0.73 0.30 0.89 0.98 0.33 0.03 0.86 0.99 0.65 0.33 0.89 0.97 
DPE/Hans GCB 150 (13) 0.73 0.35 0.91 0.98 0.29 0.03 0.87 0.99 0.65 0.38 0.91 0.97 

The test characteristics of other IHC markers and permutations are shown in supplemental Table 2.

NPV, negative predictive value; PPV, positive predictive value; sens, sensitivity; spec, specificity; UNC, unclassified DLBCL.

Close Modal

or Create an Account

Close Modal
Close Modal